Verastem, Inc. ( VSTM) - Stock Earnings
VSTM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -98.5 million USD | 11.2 million USD |
| 2025Q4 | -32.9 million USD | 17.5 million USD |
| 2026Q1 | -36.6 million USD | 18.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
VSTM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -87.4 million USD | — USD |
| 2024 | -130.6 million USD | 10.0 million USD |
| 2025 | -209.5 million USD | 30.9 million USD |
| 2026 Est. | — | — |
VSTM
Price: $4.01
52 week price:
Earnings Per Share: -2.52 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 245000
Ebitda: -22.9 millionMarket Capitalization: 257.2 million